Skip Navigation



Hum. Reprod. Advance Access published online on May 7, 2007
Human Reproduction, doi:10.1093/humrep/dem101
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
22/7/1837    most recent
dem101v2
dem101v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Tsepelidis, S.
Right arrow Articles by Englert, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsepelidis, S.
Right arrow Articles by Englert, Y.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Stable serum levels of anti-Müllerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women

S. Tsepelidis1,3, F. Devreker1,3, I. Demeestere1,3, A. Flahaut2, Ch. Gervy2 and Y. Englert1,3,4

1 Department of Obstetrics and Gynaecology, Université Libre de Bruxelles, Erasme Hospital, 808 Route de Lennik, 1070 Brussels, Belgium 2 Biochemistry Department, Université Libre de Bruxelles, 808 Route de Lennik, 1070 Brussels, Belgium 3 Research Laboratory on Human Reproduction, Faculty of Medicine, Erasme Hospital, Université Libre de Bruxelles, 808 Route de Lennik, 1070 Brussels, Belgium

4 Correspondence address. Tel: +3 22 555 4570; Fax: +3 22 555 4520; E-mail: stsepeli{at}ulb.ac.be

BACKGROUND: Anti-Müllerian hormone (AMH), secreted by the granulosa cells of preantral and small antral follicles, has been described as a potential marker of the ovarian reserve. The aim of this prospective study is to investigate the variations of AMH during the menstrual cycle in a young selected population of normo-ovulatory women and to analyse the correlation with other cyclic hormones.

METHODS: Twenty healthy volunteers from 19 to 35 years old, with regular menstrual cycles (26–31 days), normal ovulation (day 10–16), normal hormonal profile and normal body mass index (18–26 kg/m2) were recruited. AMH, inhibin B, LH, FSH, estradiol and progesterone were measured on days 3, 7, 10, 11, 12, 13, 14, 15, 16, 18, 21 and 25 of a spontaneous cycle.

RESULTS: AMH serum levels, either expressed by cycle day or aligned according to the ovulation day, did not show any significant variations during the menstrual cycle.

CONCLUSIONS: No significant fluctuation of the AMH level during the menstrual cycle was observed. Therefore, this hormone is particularly interesting for clinical evaluation of the ovarian reserve as it may be used at any time during the cycle.

Key words: anti-Müllerian hormone/MIS/menstrual cycle/ovarian function

Submitted on January 5, 2007; resubmitted on March 20, 2007; accepted on March 29, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum ReprodHome page
J. van Disseldorp, C.B. Lambalk, J. Kwee, C.W.N. Looman, M.J.C. Eijkemans, B.C. Fauser, and F.J. Broekmans
Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts
Hum. Reprod., October 19, 2009; (2009) dep366v1.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
A. La Marca, G. Sighinolfi, D. Radi, C. Argento, E. Baraldi, A. C. Artenisio, G. Stabile, and A. Volpe
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)
Hum. Reprod. Update, September 30, 2009; (2009) dmp036v1.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
A. La Marca, F.J. Broekmans, A. Volpe, B.C. Fauser, N.S. Macklon, and on behalf of the ESHRE Special Interest Group for
Anti-Mullerian hormone (AMH): what do we still need to know?
Hum. Reprod., September 1, 2009; 24(9): 2264 - 2275.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
F. J. Broekmans, M. R. Soules, and B. C. Fauser
Ovarian Aging: Mechanisms and Clinical Consequences
Endocr. Rev., August 1, 2009; 30(5): 465 - 493.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
C. Rico, S. Fabre, C. Medigue, N. d. Clemente, F. Clement, M. Bontoux, J.-L. Touze, M. Dupont, E. Briant, B. Remy, et al.
Anti-Mullerian Hormone Is an Endocrine Marker of Ovarian Gonadotropin-Responsive Follicles and Can Help to Predict Superovulatory Responses in the Cow
Biol Reprod, January 1, 2009; 80(1): 50 - 59.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
J. Rohr, E.G. Allen, K. Charen, J. Giles, W. He, C. Dominguez, and S.L. Sherman
Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study
Hum. Reprod., May 1, 2008; 23(5): 1220 - 1225.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
T.E.M. Verhagen, D.J. Hendriks, L.F.J.M.M. Bancsi, B.W.J. Mol, and F.J.M. Broekmans
The accuracy of multivariate models predicting ovarian reserve and pregnancy after in vitro fertilization: a meta-analysis
Hum. Reprod. Update, March 1, 2008; 14(2): 95 - 100.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.